A vaccine trial of the indigenous coronavirus vaccine ‘Covaxin’ has been started in Jaipur for phase 3. The trial of this biotech vaccine has been started under the supervision of the central government.
The trail of Bharat Biotech’s vaccine was conducted at Maharaja Agrasen Hospital in Vidhyadhar Nagar in Jaipur. By Friday evening, 130 volunteers were given a 0.5 mL dose of the vaccine.
Dr Manish Jain, Principal Investigator (PI) of ClinFical Trial of this vaccine and Representative Of Bharat Biotech, says that the target is to give this dose to 2 thousand volunteers in Jaipur by 31 December. If this experiment is successful, this vaccine will be available to the general public by February or March.
The vaccine has been prepared by Hyderabad-based company Bharat Biotech, National Institute Of Virology Pune and Indian Council Of Medical Research. ICMR has funded it and every trial of this is being done under the supervision of the government of India. Its earlier two-phase trials have already taken place and the results have been positive. So, it is not difficult to get volunteers for the third trial, he added.
According to Dr Manish Jain, volunteers between 18 and 65 years enrolled for the dose of the vaccine. It is being checked that they should not have any such disease like heart disease, diabetes or hypertension. Also, registration is being done and volunteers are asked to fill the concern form to participate in the trial of this vaccine at their will.
The volunteers will be given two doses of the vaccine in a gap of 28 days. After applying the first dose, they are monitored for half an hour and then they are sent home. They are constantly monitored on the telephone. However, volunteers have been told that there may be a little complaint of mild fever or pain initially. They have also been told that if they feel any other change then they should contact immediately.
